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SUMMARY
Urinary tract infection is a common problem worldwide. Its clinical characteristics and susceptibility rates of bacteria are important 
in determining the treatment of choice and its duration. This study assessed the frequency and susceptibility to antimicrobials of 
uropathogens isolated from community-acquired urinary tract infections in the city of Natal, Rio Grande do Norte State capital, 
northeastern Brazil, from 2007 to 2010. A total of 1,082 positive samples were evaluated; E. coli was the most prevalent pathogen 
(60.4%). With respect to the uropathogens susceptibility rates, the resistance of enterobacteria to ciprofloxacin and sulfamethoxazole-
trimethoprim was 24.4% and 50.6%, respectively. Susceptibility was over 90% for nitrofurantoin, aminoglycosides and third-generation 
cephalosporins. High resistance rates of uropathogens to quinolones and sulfamethoxazole-trimethoprim draws attention to the choice 
of these drugs on empirical treatments, especially in patients with pyelonephritis. Given the increased resistance of community bacteria 
to antimicrobials, local knowledge of susceptibility rates of uropathogens is essential for therapeutic decision making regarding 
patients with urinary tract infections. 
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INTRODUCTION
Urinary tract infections (UTI) are frequent problems, exceeded 
only by respiratory and gastrointestinal infections. It affects around 
150 million people worldwide each year1,2. UTI is defined as a tissue 
invasion by means of bacterial colonization of any part of the urinary 
tract, from the urethra to the kidneys3. Thus, it may involve the lower or 
upper urinary tract. Episodes of UTI occurring in premenopausal, non-
pregnant, women with no known urological abnormalities are classified 
as uncomplicated, while all others are considered complicated UTI. 
This concept and knowledge of local susceptibility rates are important 
in decision making of the optimal choice for empirical antimicrobial 
therapy and its duration1,2. 
Most UTIs are caused by Gram-negative bacteria, being Escherichia 
coli the most commonly isolated. Other bacteria involved are 
Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Enterococcus spp., Enterobacter spp., Group B Streptococcus and 
Staphylococcus saprophyticus3-5. Variations in microbial spectrum and 
susceptibility patterns may occur in different regions, and the previous 
use of antimicrobials is an important predictor of resistance5,6.
The high incidence of these infections and the need to start treatment 
before the results of microbiological findings become available often lead 
to the adoption of empirical therapy5. National and international studies 
have shown increased resistance to commonly used antimicrobials7-9. 
Besides, knowledge of the resistance pattern of uropathogens is important 
in guiding optimal antimicrobial choice in the initial approach of the 
patient. The aim of this study was to describe pathogens frequency 
and their susceptibility patterns in community-acquired urinary tract 
infections in the city of Natal, Rio Grande do Norte State capital, 
northeastern Brazil. 
MATERIALS AND METHODS
This is a retrospective study to evaluate the results of urine cultures 
taken at the Central State Laboratory (LACEN/RN), a reference center 
for microbiological examinations in the public health system of Rio 
Grande do Norte State, Brazil. Data were based on records collected 
from January 2007 to December 2010, precluding identification of the 
subjects involved. 
The urine specimens were processed and incubated on CLED agar, 
at a temperature of 35 ± 2 °C, for 24-48 hours. A count ≥ 100,000 colony 
forming units (CFU) per milliliter of urine was considered positive 
after incubation, and these isolates were identified. The antimicrobial 
susceptibility was determined on urinary isolates using the disk diffusion 
method, according to CLSI (Clinical & Laboratory Standard Institute) 
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recommendations. In addition, susceptibility test results were interpreted 
following CLSI standards and recommendations (2005)10 and, for the 
purpose of the analysis, intermediate susceptibility was interpreted as 
resistance. Only aerobic bacterial infections were analyzed in this study. 
Cultures showing fungal growth, mixed growth and those not conclusive 
in the laboratory, irrespective of reason, were excluded.
The data were analyzed using Excel 2007®. Susceptibility to 
antimicrobials was calculated by species.
RESULTS
A total of 1,082 samples were considered positive, according to 
inclusion microbiological criteria. Of these, 836 (79%) were from women. 
The median age of patients at time of treatment was 68.3 years (range 
three months–95 years). Among those with positive samples, 346 (31.9%) 
were older than the age of 60; of these, 221 (63.9% of people aged 60 
and over) were female. We do not have data on how many samples were 
from patients treated in primary care facilities, but, in Natal/RN, the 
LACEN/RN laboratory is responsible for the execution of exams sent 
from the primary care facilities, while nosocomial samples are analyzed 
in hospital laboratories. 
Among the positive samples, the most common pathogen isolated 
was E. coli (653/60.4%), followed by Klebsiella spp. (154/14.2%), 
Staphylococcus spp. (78/7.2%), and Proteus spp. (52/4.8%). Data are 
summarized in Tables 1 and 2. 
Resistance to ciprofloxacin was identified in 24.4% of E. coli and 
Klebsiella spp., 30.2% of Proteus spp., and 9.4% of Staphylococcus 
spp. Resistance to sulfamethoxazole-trimethoprim was 50.6% for E. 
coli, 34.4% for Klebsiella spp., 53.8% for Proteus spp., and 18.6% 
for Staphylococcus spp. Susceptibility to ceftriaxone was 92.2% for 
E. coli, 86.1% for Klebsiella spp., and 80.0% for Proteus spp. E. coli 
was susceptible to nitrofurantoin in 93.4% of the samples. Resistance 
to cephalothin was 57.2% for E. coli, 27.7% for Klebsiella spp., and 
44.4% for Proteus spp.; 43.7% of Staphylococcus spp. were resistant to 
oxacillin. In relation to aminoglycosides, susceptibility to amikacin was 
94.1% for E. coli, 92.7% for Klebsiella spp., and 87.5% for Proteus spp.
DISCUSSION
The present study provides information regarding species that 
cause community-acquired urinary tract infection treated at public 
Table 1 
Antimicrobial susceptibility of the three main uropathogens from Family Enterobacteriaceae . January 2007 to December 2010, LACEN/RN.
Antimicrobials
% Susceptible
E.coli 
(n=653)
Klebsiella spp. 
(n=154)
Proteus spp. 
(n=52)
Amikacin 94.1 92.7 87.5
Gentamicin 92.1 81.7 78.1
Ampicillin 48.3 - -
Ampicillin/sulbactam 52.0 72.2 80.0
Amoxicillin/Clavulanate 82.2 81.1 95.7
Cephalothin 42.8 72.3 55.6
Ceftriaxone 92.2 86.1 80.0
Cefepime 90.8 73.2 76.0
Ciprofloxacin 75.6 75.4 69.8
Norfloxacin 79.6 76.5 75.0
Nitrofurantoin 93.4 45.1 15.6
Sulfamethoxazole/Trimethoprim 49.4 65.6 46.2
Nalidixic Acid 68.4 60.6 44.4
Table 2 
Antimicrobial susceptibility of Staphylococcus spp.isolated from urine. January 
2007 to December 2010, LACEN/RN.
Antimicrobials
% Susceptible
Staphylococcus spp 
(n=78)
Amikacin 33.3
Gentamicin 84.3
Ciprofloxacin 90.6
Norfloxacin 94.4
Nitrofurantoin 98.2
Oxacillin 56.3
Sulfamethoxazole/Trimethoprim 81.4
Nalidixic Acid 14.3
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health services in Natal, Brazil, and their susceptibility to the main 
antimicrobials. Most of the samples were from patients treated at primary 
care facilities, and 79% were from women. There was no discrimination 
between asymptomatic bacteriuria, complicated, and uncomplicated 
UTI. E. coli predominated among the isolated agents, accounting for 
60% of the positive cultures. This value is lower than that found in a 
number of international studies and similar to that obtained in Brazilian 
studies1,5,8,9,11, which might reveal a local characteristic, reaffirming the 
need to know the regional profile in order to choose the correct antibiotic 
and course of empirical treatment. 
Furthermore, we had a high percentage of samples from people aged 
60 and over (31.9%), predominantly women. Older people, especially 
women, have the highest incidence of asymptomatic bacteriuria and UTIs 
and more associated comorbidities, like diabetes, considered an important 
risk factor for recurrent UTIs in women12. The antimicrobial use in this 
group is very frequent, because of recurrent UTIs, mistaken treatment for 
asymptomatic bacteriuria, or treatment of others infections12. It is possible 
that part of the study population had history of previous antimicrobial use 
or previous hospitalization. These factors have probably contributed to 
pathogen distribution and the sensitivity profile in this study, with high 
resistance of Gram-negative Enterobacteriaceae to quinolones and high 
resistance of Staphylococcus spp. to oxacillin.
Escherichia coli, Klebsiella spp., and Staphylococcus spp. 
were isolated in 82% of the samples, and most were susceptible to 
nitrofurantoin (> 92%), excepting for Klebsiella spp. strains (45%). 
Therefore, these data reinforce the recommendation of various clinical 
guidelines related to the empirical prescription of nitrofurantoin for 
uncomplicated cystitis. Fosfomycin, also recommended for these 
situations, was not tested in our study7,13-15. 
Fluoroquinolones are widely used for empirical treatment of UTI, 
including the cases of upper urinary tract infections9. We observed high 
resistance rates of the main isolated species to the tested antimicrobials 
(> 25% for E. coli). Similar data were described by ANDRADE et 
al., in samples of five Latin American countries (Argentina, Chile, 
Brazil, Mexico, and Venezuela)7. The previous use of quinolones 
is an independent risk factor for resistance to ciprofloxacin16. The 
indiscriminate use of this class of antimicrobials in community-acquired 
infections may have contributed to the high percentage of resistance 
observed, considering that the Brazilian population had free over-the-
counter access to antimicrobials until 2011 (Resolution No. 20 of the 
Collegiate Board – RDC, on May 5, 2011). Therefore, quinolones as 
empirical therapy must be considered carefully, especially for patients 
with pyelonephritis. In this respect, if susceptibility is confirmed by 
pathogen isolation, quinolones are alternatives for de-escalation therapy, 
given the possibility of their oral administration17.
Most of the E. coli strains isolated (50.6%) and other species were 
resistant to sulfamethoxazole-trimethoprim, as described in earlier 
studies5,7. This finding is most probably due to the wide use of these 
antimicrobials in the treatment of community-acquired infections. 
Even though sulfamethoxazole-trimethoprim is one of the alternatives 
for the empirical treatment of uncomplicated cystitis, therefore this 
association is not a safe choice. Guidelines of the American Infectious 
Diseases Society and the European Society for Microbiology and 
Infectious Diseases suggest that antimicrobials with a resistance rate 
above 20% should not be prescribed empirically to patients with 
uncomplicated cystitis, unless susceptibility is determined by prior 
isolation in culture17.
In pregnant women, asymptomatic bacteriuria and UTI are common 
problems that should be treated with proper antimicrobials, due to a 
greater risk of pyelonephritis and the relationship between asymptomatic 
bacteriuria and obstetric complications18,19. The high percentage of strains 
resistant to first-generation cephalosporins and amoxicillin in our sample 
limits the empirical use of these drugs in pregnant women. Under these 
circumstances, nitrofurantoin, fosfomycin or amoxicillin/clavulanate 
are safer alternatives for cystitis, while third-generation cephalosporins 
should be used for pyelonephritis, until the susceptibility test of the 
isolated bacteria is available17,20.
The high susceptibility to third-generation cephalosporins and 
aminoglycosides (> 90% in most strains), as well as their pharmacokinetic 
characteristics, make them the first line of therapy for pyelonephritis, 
until microbiological data are known. 
The authors underscore the importance of knowledge of the local 
antimicrobial susceptibility pattern in the decision making of the 
therapy for UTI, given the increased resistance of community bacteria 
to antimicrobials commonly prescribed for this condition.
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